Appraisal Economics provides valuation services for leading companies in the healthcare industry including such firms as Allergan, Bristol-Myers Squibb, Centocor, Imclone Systems, Merck, and Taro Pharmaceuticals, among others.
Experience
We serve a wide range of medical, pharmaceutical, and biotech companies that provide various goods and services, including:
- Manufacturing medical devices, equipment, and technology
- Medical practices, dental practices, and other healthcare providers
- Researching and production of new drugs
- Producing generic equivalents
- Manufacturing animal care products and equipment
Recent Valuation Projects
Some of our recent projects have been to:
- Opine on the solvency of a healthcare services company for a potential debt recapitalization and dividend
- Value incentive compensation granted to a biopharmaceutical company’s CEO
- Determine the present value of the patent for a molecule that may treat certain cancers
- Value groups of medical and dental practices for acquisition by integrated healthcare delivery systems
- Value a medical imaging company in connection with a recapitalization
- Opine on the fairness of a transaction of a company developing a new progesterone therapy
- Allocate the purchase price for a leading pharmaceutical company among its trademarks, customer lists, new drug applications, non-compete agreements, contracts, licenses, permits, and favorable leases
- Review valuation reports prepared by a major accounting firm to assess the reasonableness of the valuation methodologies and assumptions used and the conclusions reached, for a global biopharmaceutical company
- Establish the market value of an animal pharmaceutical company’s real property, including a development plant and a quality control facility
Contact Us
Appraisal Economics has provided valuation services for clients in the medical, pharmaceutical, and biotech industry for over 30 years. We understand the intricacies of this industry and are equipped to handle your particular needs. Please contact us or call +1 201 265 3333 for more information.
Articles and Publications
To read any of our publications, please visit our Resources page. Our latest report on the automotive industry is available here.